BIOSEV S.A.

PUBLICLY HELD COMPANY

CNPJ: 15.527.906/0001-36

NIRE: 35.3.0034518.5

CVM: 22845

MINUTES OF THE BOARD OF DIRECTOR´S EXTRAORDINARY MEETING OF MAY 24, 2021 ("MEETING"),

RECORDED IN SUMMARY FORM

  1. Date, time and place: May 24, 2021, at 01:00 pm (São Paulo time zone), at the headquarters of Biosev S.A. ("Company"), located at Avenida Brigadeiro Faria Lima, No. 1.355, 11th floor, Pinheiros, in the city of São Paulo, State of São Paulo, Brazil, 01452-919. The Board members participated in the Meeting via video conference, pursuant to article 11, paragraph 2, of the Company's Bylaws.
  2. Attendance: The following Board members of the Company attended the Meeting, all via video conference: Adrian Gustavo Isman, Patrick Julien Treuer, Enrico Biancheri, André Roth, Federico Adrian Cerisoli, Neil Roxburgh Balfour, Philippe Jean Henri Delleur and Ricardo Barbosa Leonardos. The following persons also attended the Meeting as guests and via video conference: Juan Blanchard, Leonardo Oliveira D'Elia, Daniela Agnes Luci Gragnoli Aragão Lamoglia and Georges Edouard Duriez, all of whom are members of the Company's management.
  3. Chairman and Secretary: Mr. Adrian Gustavo Isman chaired the Meeting and Ms. Daniela Agnes Luci Gragnoli Aragão Lamoglia acted as Secretary.
  4. Agenda: Resolve on the following acts related to the merger of shares issued by the Company into Hédera
    Investimentos e Participações S.A. ("Hédera" and "Merger of Shares"), approved at the Company's Extraordinary General Meeting held on April 8, 2021 ("Shareholders' Meeting"): (a) the cancellation of the Company's registration as a publicly-held company before the Brazilian Securities and Exchange Commission ("CVM"), pursuant to articles
  1. and 48 of CVM Instruction 480, of December 7, 2009, as amended, and article 8, item xiii of the Company's Bylaws ("Cancellation of Registration"); and (b) the cancellation of the Company's listing on B3 S. A. - Brasil, Bolsa, Balcão ("B3"), pursuant to items 9.1 and 9.2 of the Regulation for the Listing of Issuers and for the Admission of Securities for Trading and item 9.1 of the Issuer's Manual.
  1. Presentation and Discussions: A presentation was made regarding the topics of the agenda. After the presentation, the Board members discussed and clarified their questions about the presentation, and there were no further questions or objections to what was presented or to what was clarified.
  2. Resolutions: The Board members who were present at the Meeting, unanimously and without any reservations, approved: (a) the Cancellation of Registration, as defined above; and (b) the Cancellation of Listing, as defined above, authorizing the officers of the Company to take all necessary measures to implement the referred resolutions, including, without limitation, to submit such matters to the Company's Extraordinary Shareholders' Meeting for resolution, as well as, upon approval by the shareholder Hédera, to submit to the CVM and B3, respectively, the requests for Cancellation of Registration and Cancellation of Listing, and to perform all other acts necessary for the effectiveness of the referred cancellations.

7. Closure: There being no further matters to discuss, the Meeting was adjourned. The minutes of the Meeting were drawn up, read and approved by all attending Board members.

São Paulo, May 24, 2021.

Signatures:

ADRIAN GUSTAVO ISMAN

DANIELA AGNES LUCI GRAGNOLI ARAGÃO

Chairman of the Meeting

LAMOGLIA

Secretary of the Meeting

ADRIAN GUSTAVO ISMAN

PATRICK J. TREUER

Board Member

Board Member

FEDERICO ADRIAN CERISOLI

ANDRÉ ROTH

Board Member

Board Member

ENRICO BIANCHERI

RICARDO BARBOSA LEONARDOS

Board Member

Board Member

PHILIPPE JEAN HENRI DELLEUR

NEIL ROXBURGH BALFOUR

Board Member

Board Member

Attachments

  • Original document
  • Permalink

Disclaimer

Biosev SA published this content on 25 May 2021 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 25 May 2021 23:20:03 UTC.